Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
OTC Drug market report explains the definition, types, applications, major countries, and major players of the OTC Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Eisai
Chr Hansen
Pfizer
Bayer HealthCare
Friggs
Bristol Myers Squibb
Cipla
Eli Lilly
AstraZeneca
Daiichi Sankyo
Sanofi
Johnson&Johnson
CoLucid
DSM
GlaxoSmithKline (GSK)
Euradite
BioGaia
Herbalife
Bukwang Pharmaceutica
By Type:
Class A
Class B
By End-User:
Hospital
Clinic
Household
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global OTC Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 OTC Drug Outlook to 2028- Original Forecasts
-
2.2 OTC Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term OTC Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global OTC Drug Market- Recent Developments
-
6.1 OTC Drug Market News and Developments
-
6.2 OTC Drug Market Deals Landscape
7 OTC Drug Raw Materials and Cost Structure Analysis
-
7.1 OTC Drug Key Raw Materials
-
7.2 OTC Drug Price Trend of Key Raw Materials
-
7.3 OTC Drug Key Suppliers of Raw Materials
-
7.4 OTC Drug Market Concentration Rate of Raw Materials
-
7.5 OTC Drug Cost Structure Analysis
-
7.5.1 OTC Drug Raw Materials Analysis
-
7.5.2 OTC Drug Labor Cost Analysis
-
7.5.3 OTC Drug Manufacturing Expenses Analysis
8 Global OTC Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global OTC Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global OTC Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global OTC Drug Market Outlook by Types and Applications to 2022
-
9.1 Global OTC Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Class A Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Class B Consumption and Growth Rate (2017-2022)
-
9.2 Global OTC Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Household Consumption and Growth Rate (2017-2022)
10 Region and Country-wise OTC Drug Market Analysis and Outlook till 2022
-
10.1 Global OTC Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States OTC Drug Consumption (2017-2022)
-
10.2.2 Canada OTC Drug Consumption (2017-2022)
-
10.2.3 Mexico OTC Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany OTC Drug Consumption (2017-2022)
-
10.3.2 UK OTC Drug Consumption (2017-2022)
-
10.3.3 Spain OTC Drug Consumption (2017-2022)
-
10.3.4 Belgium OTC Drug Consumption (2017-2022)
-
10.3.5 France OTC Drug Consumption (2017-2022)
-
10.3.6 Italy OTC Drug Consumption (2017-2022)
-
10.3.7 Denmark OTC Drug Consumption (2017-2022)
-
10.3.8 Finland OTC Drug Consumption (2017-2022)
-
10.3.9 Norway OTC Drug Consumption (2017-2022)
-
10.3.10 Sweden OTC Drug Consumption (2017-2022)
-
10.3.11 Poland OTC Drug Consumption (2017-2022)
-
10.3.12 Russia OTC Drug Consumption (2017-2022)
-
10.3.13 Turkey OTC Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China OTC Drug Consumption (2017-2022)
-
10.4.2 Japan OTC Drug Consumption (2017-2022)
-
10.4.3 India OTC Drug Consumption (2017-2022)
-
10.4.4 South Korea OTC Drug Consumption (2017-2022)
-
10.4.5 Pakistan OTC Drug Consumption (2017-2022)
-
10.4.6 Bangladesh OTC Drug Consumption (2017-2022)
-
10.4.7 Indonesia OTC Drug Consumption (2017-2022)
-
10.4.8 Thailand OTC Drug Consumption (2017-2022)
-
10.4.9 Singapore OTC Drug Consumption (2017-2022)
-
10.4.10 Malaysia OTC Drug Consumption (2017-2022)
-
10.4.11 Philippines OTC Drug Consumption (2017-2022)
-
10.4.12 Vietnam OTC Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil OTC Drug Consumption (2017-2022)
-
10.5.2 Colombia OTC Drug Consumption (2017-2022)
-
10.5.3 Chile OTC Drug Consumption (2017-2022)
-
10.5.4 Argentina OTC Drug Consumption (2017-2022)
-
10.5.5 Venezuela OTC Drug Consumption (2017-2022)
-
10.5.6 Peru OTC Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico OTC Drug Consumption (2017-2022)
-
10.5.8 Ecuador OTC Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain OTC Drug Consumption (2017-2022)
-
10.6.2 Kuwait OTC Drug Consumption (2017-2022)
-
10.6.3 Oman OTC Drug Consumption (2017-2022)
-
10.6.4 Qatar OTC Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia OTC Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates OTC Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria OTC Drug Consumption (2017-2022)
-
10.7.2 South Africa OTC Drug Consumption (2017-2022)
-
10.7.3 Egypt OTC Drug Consumption (2017-2022)
-
10.7.4 Algeria OTC Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia OTC Drug Consumption (2017-2022)
-
10.8.2 New Zealand OTC Drug Consumption (2017-2022)
11 Global OTC Drug Competitive Analysis
-
11.1 Eisai
-
11.1.1 Eisai Company Details
-
11.1.2 Eisai OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Eisai OTC Drug Main Business and Markets Served
-
11.1.4 Eisai OTC Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Chr Hansen
-
11.2.1 Chr Hansen Company Details
-
11.2.2 Chr Hansen OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Chr Hansen OTC Drug Main Business and Markets Served
-
11.2.4 Chr Hansen OTC Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer
-
11.3.1 Pfizer Company Details
-
11.3.2 Pfizer OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer OTC Drug Main Business and Markets Served
-
11.3.4 Pfizer OTC Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bayer HealthCare
-
11.4.1 Bayer HealthCare Company Details
-
11.4.2 Bayer HealthCare OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bayer HealthCare OTC Drug Main Business and Markets Served
-
11.4.4 Bayer HealthCare OTC Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Friggs
-
11.5.1 Friggs Company Details
-
11.5.2 Friggs OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Friggs OTC Drug Main Business and Markets Served
-
11.5.4 Friggs OTC Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bristol Myers Squibb
-
11.6.1 Bristol Myers Squibb Company Details
-
11.6.2 Bristol Myers Squibb OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bristol Myers Squibb OTC Drug Main Business and Markets Served
-
11.6.4 Bristol Myers Squibb OTC Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Cipla
-
11.7.1 Cipla Company Details
-
11.7.2 Cipla OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Cipla OTC Drug Main Business and Markets Served
-
11.7.4 Cipla OTC Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Eli Lilly
-
11.8.1 Eli Lilly Company Details
-
11.8.2 Eli Lilly OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Eli Lilly OTC Drug Main Business and Markets Served
-
11.8.4 Eli Lilly OTC Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 AstraZeneca
-
11.9.1 AstraZeneca Company Details
-
11.9.2 AstraZeneca OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 AstraZeneca OTC Drug Main Business and Markets Served
-
11.9.4 AstraZeneca OTC Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Daiichi Sankyo
-
11.10.1 Daiichi Sankyo Company Details
-
11.10.2 Daiichi Sankyo OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Daiichi Sankyo OTC Drug Main Business and Markets Served
-
11.10.4 Daiichi Sankyo OTC Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sanofi
-
11.11.1 Sanofi Company Details
-
11.11.2 Sanofi OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sanofi OTC Drug Main Business and Markets Served
-
11.11.4 Sanofi OTC Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Johnson&Johnson
-
11.12.1 Johnson&Johnson Company Details
-
11.12.2 Johnson&Johnson OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Johnson&Johnson OTC Drug Main Business and Markets Served
-
11.12.4 Johnson&Johnson OTC Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 CoLucid
-
11.13.1 CoLucid Company Details
-
11.13.2 CoLucid OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 CoLucid OTC Drug Main Business and Markets Served
-
11.13.4 CoLucid OTC Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 DSM
-
11.14.1 DSM Company Details
-
11.14.2 DSM OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 DSM OTC Drug Main Business and Markets Served
-
11.14.4 DSM OTC Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 GlaxoSmithKline (GSK)
-
11.15.1 GlaxoSmithKline (GSK) Company Details
-
11.15.2 GlaxoSmithKline (GSK) OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 GlaxoSmithKline (GSK) OTC Drug Main Business and Markets Served
-
11.15.4 GlaxoSmithKline (GSK) OTC Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Euradite
-
11.16.1 Euradite Company Details
-
11.16.2 Euradite OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Euradite OTC Drug Main Business and Markets Served
-
11.16.4 Euradite OTC Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 BioGaia
-
11.17.1 BioGaia Company Details
-
11.17.2 BioGaia OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 BioGaia OTC Drug Main Business and Markets Served
-
11.17.4 BioGaia OTC Drug Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Herbalife
-
11.18.1 Herbalife Company Details
-
11.18.2 Herbalife OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Herbalife OTC Drug Main Business and Markets Served
-
11.18.4 Herbalife OTC Drug Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Bukwang Pharmaceutica
-
11.19.1 Bukwang Pharmaceutica Company Details
-
11.19.2 Bukwang Pharmaceutica OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Bukwang Pharmaceutica OTC Drug Main Business and Markets Served
-
11.19.4 Bukwang Pharmaceutica OTC Drug Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global OTC Drug Market Outlook by Types and Applications to 2028
-
12.1 Global OTC Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Class A Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Class B Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global OTC Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise OTC Drug Market Analysis and Outlook to 2028
-
13.1 Global OTC Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States OTC Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada OTC Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico OTC Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany OTC Drug Consumption Forecast (2022-2028)
-
13.3.2 UK OTC Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain OTC Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium OTC Drug Consumption Forecast (2022-2028)
-
13.3.5 France OTC Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy OTC Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark OTC Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland OTC Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway OTC Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden OTC Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland OTC Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia OTC Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey OTC Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China OTC Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan OTC Drug Consumption Forecast (2022-2028)
-
13.4.3 India OTC Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea OTC Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan OTC Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh OTC Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia OTC Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand OTC Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore OTC Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia OTC Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines OTC Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam OTC Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil OTC Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia OTC Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile OTC Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina OTC Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela OTC Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru OTC Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico OTC Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador OTC Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain OTC Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait OTC Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman OTC Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar OTC Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia OTC Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates OTC Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria OTC Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa OTC Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt OTC Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria OTC Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia OTC Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand OTC Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of OTC Drug
-
Figure of OTC Drug Picture
-
Table Global OTC Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global OTC Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Class A Consumption and Growth Rate (2017-2022)
-
Figure Global Class B Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Drug Consumption by Country (2017-2022)
-
Table North America OTC Drug Consumption by Country (2017-2022)
-
Figure United States OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico OTC Drug Consumption and Growth Rate (2017-2022)
-
Table Europe OTC Drug Consumption by Country (2017-2022)
-
Figure Germany OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure UK OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure France OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey OTC Drug Consumption and Growth Rate (2017-2022)
-
Table APAC OTC Drug Consumption by Country (2017-2022)
-
Figure China OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure India OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam OTC Drug Consumption and Growth Rate (2017-2022)
-
Table South America OTC Drug Consumption by Country (2017-2022)
-
Figure Brazil OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador OTC Drug Consumption and Growth Rate (2017-2022)
-
Table GCC OTC Drug Consumption by Country (2017-2022)
-
Figure Bahrain OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates OTC Drug Consumption and Growth Rate (2017-2022)
-
Table Africa OTC Drug Consumption by Country (2017-2022)
-
Figure Nigeria OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria OTC Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania OTC Drug Consumption by Country (2017-2022)
-
Figure Australia OTC Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand OTC Drug Consumption and Growth Rate (2017-2022)
-
Table Eisai Company Details
-
Table Eisai OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai OTC Drug Main Business and Markets Served
-
Table Eisai OTC Drug Product Portfolio
-
Table Chr Hansen Company Details
-
Table Chr Hansen OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chr Hansen OTC Drug Main Business and Markets Served
-
Table Chr Hansen OTC Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer OTC Drug Main Business and Markets Served
-
Table Pfizer OTC Drug Product Portfolio
-
Table Bayer HealthCare Company Details
-
Table Bayer HealthCare OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare OTC Drug Main Business and Markets Served
-
Table Bayer HealthCare OTC Drug Product Portfolio
-
Table Friggs Company Details
-
Table Friggs OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Friggs OTC Drug Main Business and Markets Served
-
Table Friggs OTC Drug Product Portfolio
-
Table Bristol Myers Squibb Company Details
-
Table Bristol Myers Squibb OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb OTC Drug Main Business and Markets Served
-
Table Bristol Myers Squibb OTC Drug Product Portfolio
-
Table Cipla Company Details
-
Table Cipla OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla OTC Drug Main Business and Markets Served
-
Table Cipla OTC Drug Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly OTC Drug Main Business and Markets Served
-
Table Eli Lilly OTC Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca OTC Drug Main Business and Markets Served
-
Table AstraZeneca OTC Drug Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo OTC Drug Main Business and Markets Served
-
Table Daiichi Sankyo OTC Drug Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi OTC Drug Main Business and Markets Served
-
Table Sanofi OTC Drug Product Portfolio
-
Table Johnson&Johnson Company Details
-
Table Johnson&Johnson OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson&Johnson OTC Drug Main Business and Markets Served
-
Table Johnson&Johnson OTC Drug Product Portfolio
-
Table CoLucid Company Details
-
Table CoLucid OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CoLucid OTC Drug Main Business and Markets Served
-
Table CoLucid OTC Drug Product Portfolio
-
Table DSM Company Details
-
Table DSM OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table DSM OTC Drug Main Business and Markets Served
-
Table DSM OTC Drug Product Portfolio
-
Table GlaxoSmithKline (GSK) Company Details
-
Table GlaxoSmithKline (GSK) OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline (GSK) OTC Drug Main Business and Markets Served
-
Table GlaxoSmithKline (GSK) OTC Drug Product Portfolio
-
Table Euradite Company Details
-
Table Euradite OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Euradite OTC Drug Main Business and Markets Served
-
Table Euradite OTC Drug Product Portfolio
-
Table BioGaia Company Details
-
Table BioGaia OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioGaia OTC Drug Main Business and Markets Served
-
Table BioGaia OTC Drug Product Portfolio
-
Table Herbalife Company Details
-
Table Herbalife OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Herbalife OTC Drug Main Business and Markets Served
-
Table Herbalife OTC Drug Product Portfolio
-
Table Bukwang Pharmaceutica Company Details
-
Table Bukwang Pharmaceutica OTC Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bukwang Pharmaceutica OTC Drug Main Business and Markets Served
-
Table Bukwang Pharmaceutica OTC Drug Product Portfolio
-
Figure Global Class A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Class B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Drug Consumption Forecast by Country (2022-2028)
-
Table North America OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure United States OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure China OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania OTC Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand OTC Drug Consumption Forecast and Growth Rate (2022-2028)
-
